All Curated Mutation Sites in ZIKV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in ZIKV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
C
  
E
  
M
  
NS1
  
NS2A
  
NS2B
  
NS3
  
NS4B
  
NS5
  
prM
  
FWR
  

Keyword: Guillain-Barre Syndrome-39561198
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 39561198 C4167T Guillain-Barre Syndrome
G
R
S
L
View
2 39561198 A248V
E
envelope
Guillain-Barre Syndrome
G
R
S
L
View
3 39561198 V330L
E
envelope
Guillain-Barre Syndrome
G
R
S
L
View
4 39561198 E142K
NS1
NS1
Guillain-Barre Syndrome
G
R
S
L
View
5 39561198 R276Q
NS1
NS1
Guillain-Barre Syndrome
G
R
S
L
View
6 39561198 R324W
NS1
NS1
Guillain-Barre Syndrome
G
R
S
L
View
7 39561198 I115T
NS3
NS3
Guillain-Barre Syndrome
G
R
S
L
View
8 39561198 I283V
NS3
NS3
Guillain-Barre Syndrome
G
R
S
L
View
9 39561198 S356F
NS3
NS3
Guillain-Barre Syndrome
G
R
S
L
View
10 39561198 T25A
NS4B
NS4B
Guillain-Barre Syndrome
G
R
S
L
View
11 39561198 I345M
NS5
NS5
Guillain-Barre Syndrome
G
R
S
L
View
12 39561198 L195M
NS5
NS5
Guillain-Barre Syndrome
G
R
S
L
View
13 39561198 T833A
NS5
NS5
Guillain-Barre Syndrome
G
R
S
L
View
14 39561198 A88V
prM
prM
Guillain-Barre Syndrome
G
R
S
L
View
15 39561198 K85R
prM
prM
Guillain-Barre Syndrome
G
R
S
L
View
Contents
Description

The table shows all curated mutation sites of ZIKV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.